Spots Global Cancer Trial Database for chinese
Every month we try and update this database with for chinese cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study to Evaluate Effectiveness of Sublobar Dissection in Patients With Non-small Cell Lung Cancer | NCT03427567 | Non-small Cell ... | Sublobar dissec... | 18 Years - | Tongji Hospital | |
| A Study on Association Between HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer | NCT04651920 | Epithelial Ovar... Chinese Homologous Reco... BRCA1 Mutation BRCA2 Mutation Prognosis Homologous Reco... | Evaluation of h... | 18 Years - | Peking Union Medical College Hospital | |
| Guangzhou Nutrition and Health Study (GNHS) | NCT03179657 | Cardiovascular ... Osteoporosis Diabetes Mellit... Metabolic Syndr... Obesity Hypertension Non-Alcoholic F... Chronic Kidney ... Cancer Death Nutrition Disor... Sarcopenia | 40 Years - 83 Years | Sun Yat-sen University | ||
| Hong Kong Breast Cancer Study | NCT02889458 | Breast Cancer Ductal Carcinom... | Not Provided | 18 Years - | The University of Hong Kong | |
| Capivasertib China PK Study | NCT04742036 | Advanced Solid ... | Capivasertib Paclitaxel | 18 Years - 130 Years | AstraZeneca | |
| Capivasertib China PK Study | NCT04742036 | Advanced Solid ... | Capivasertib Paclitaxel | 18 Years - 130 Years | AstraZeneca | |
| Nanshan Elderly Cohort Study | NCT03569735 | Hypertension Type 2 Diabetes... Cardiovascular ... Stroke Obesity Metabolic Syndr... Sarcopenia Chronic Kidney ... Cancer Death | 65 Years - | Sun Yat-sen University | ||
| A Study to Evaluate Effectiveness and Safety of Surgeries in Elderly NSCLC Patients | NCT03429673 | Non-small Cell ... | Surgeries | 65 Years - | China-Japan Friendship Hospital | |
| A Study of LY3537982 in Chinese Participants With Advanced Solid Tumors | NCT06235983 | Advanced Solid ... | LY3537982 | 18 Years - | Eli Lilly and Company | |
| The Role of Different Cycles of Chemotherapy（Capecitabine-oxaliplatin） in Esophageal Chemoradiotherapy | NCT02604615 | Stage III Esoph... Esophageal Neop... | Capecitabine(Ai... Oxaliplatin(Aih... Radiotherapy | 45 Years - 75 Years | The First Affiliated Hospital of Henan University of Science and Technology | |
| A Study to Evaluate Effectiveness of Sublobar Dissection in Patients With Non-small Cell Lung Cancer | NCT03427567 | Non-small Cell ... | Sublobar dissec... | 18 Years - | Tongji Hospital | |
| The Study of Molecular Risk Panels (70-gene Assay) in Chinese Breast Cancer Patients | NCT02669745 | Chinese | 18 Years - 70 Years | Agendia | ||
| A Study to Evaluate Clinical Characteristics of Lung Cancer in Patients With Surgeries and Adjuvant Therapies | NCT03421093 | Lung Cancer | Surgeries | 18 Years - | West China Hospital | |
| A Study to Explore Prognoses of the Patients With N2 Non-small Cell Lung Cancer | NCT03451526 | Non-small Cell ... | Surgeries | 18 Years - | Tang-Du Hospital | |
| Hong Kong Breast Cancer Study | NCT02889458 | Breast Cancer Ductal Carcinom... | Not Provided | 18 Years - | The University of Hong Kong | |
| An Observational Study to Explore Clinical Characteristics of the Patients With T1 Non-small Cell Lung Cancer | NCT03413956 | Non Small Cell ... | Surgeries | - | Jiangsu Cancer Institute & Hospital | |
| A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study | NCT03355820 | Cervical Intrae... | Blood sampling ... | 17 Years - | GlaxoSmithKline | |
| A Study to Explore Prognoses of NSCLC Patients Complicated With Oligometastases | NCT03427541 | Non Small Cell ... | Surgeries | - | Tang-Du Hospital | |
| Palbociclib Pharmacokinetics Study In Postmenopausal Chinese Women With ER (+), HER2 (-) Advanced Breast Cancer | NCT02499146 | Advanced Breast... | Palbociclib Letrozole | 18 Years - 65 Years | Pfizer | |
| A Culturally Sensitive Social Support Intervention | NCT02946697 | Breast Cancer Breast Neoplasm... | Social support ... | 18 Years - | M.D. Anderson Cancer Center | |
| Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis | NCT04160897 | Hepatitis B, Ch... Hepatocellular ... Compensated Cir... | Entecavir Tenofovir Disop... | 18 Years - 80 Years | Ruijin Hospital | |
| A Study of Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN) | NCT04590235 | Neurofibromatos... Neurofibroma Pl... | Selumetinib | 3 Years - 99 Years | AstraZeneca | |
| A Study to Explore Prognoses of NSCLC Patients Complicated With Oligometastases | NCT03427541 | Non Small Cell ... | Surgeries | - | Tang-Du Hospital | |
| The Role of Different Cycles of Chemotherapy（Capecitabine-oxaliplatin） in Esophageal Chemoradiotherapy | NCT02604615 | Stage III Esoph... Esophageal Neop... | Capecitabine(Ai... Oxaliplatin(Aih... Radiotherapy | 45 Years - 75 Years | The First Affiliated Hospital of Henan University of Science and Technology | |
| Safety And Efficacy Study Of Sunitinib Malate In Chinese Patients With Imatinib Resistant Or Intolerant Malignant Gastrointestinal Stromal Tumor | NCT00793871 | Gastrointestina... | Sunitinib Malat... | 18 Years - | Pfizer | |
| CCCG-ALCL-2020 for Chinese Children and Adolescents With Newly Diagnosed High-risk ALCL | NCT04881838 | Pediatric Anapl... | P regimen Course A1 + Vin Course B1 +Vin Course A2 + Vin Course B2 +Vin Course A3 + Vin Course B3 +Vin Maintenance the... | - 18 Years | Children's Cancer Group, China | |
| Nanshan Elderly Cohort Study | NCT03569735 | Hypertension Type 2 Diabetes... Cardiovascular ... Stroke Obesity Metabolic Syndr... Sarcopenia Chronic Kidney ... Cancer Death | 65 Years - | Sun Yat-sen University | ||
| A Study to Evaluate Effectiveness of Sublobar Dissection in Patients With Non-small Cell Lung Cancer | NCT03427567 | Non-small Cell ... | Sublobar dissec... | 18 Years - | Tongji Hospital | |
| A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study | NCT03355820 | Cervical Intrae... | Blood sampling ... | 17 Years - | GlaxoSmithKline | |
| CCCG-ALCL-2020 for Chinese Children and Adolescents With Newly Diagnosed High-risk ALCL | NCT04881838 | Pediatric Anapl... | P regimen Course A1 + Vin Course B1 +Vin Course A2 + Vin Course B2 +Vin Course A3 + Vin Course B3 +Vin Maintenance the... | - 18 Years | Children's Cancer Group, China | |
| Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer | NCT04190667 | Epithelial Ovar... Chinese Homologous Reco... BRCA1 Mutation BRCA2 Mutation Prognosis | Genomic testing | 18 Years - | Peking Union Medical College Hospital | |
| Guangzhou Nutrition and Health Study (GNHS) | NCT03179657 | Cardiovascular ... Osteoporosis Diabetes Mellit... Metabolic Syndr... Obesity Hypertension Non-Alcoholic F... Chronic Kidney ... Cancer Death Nutrition Disor... Sarcopenia | 40 Years - 83 Years | Sun Yat-sen University | ||
| Multicenter Observational Study of Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Rare Driver Gene Mutation | NCT04137718 | Chinese Non-Small Cell ... | nonIntervention | 18 Years - | Shanghai Pulmonary Hospital, Shanghai, China | |
| Ulipristal Use in Chinese Population | NCT02825719 | Fibroid | Ulipristal acet... Placebo pills Ferrous sulphat... Tranexamic Acid | 18 Years - | Queen Mary Hospital, Hong Kong | |
| A Study of LY3537982 in Chinese Participants With Advanced Solid Tumors | NCT06235983 | Advanced Solid ... | LY3537982 | 18 Years - | Eli Lilly and Company |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
